TrialPloS one2011

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.

Sandra L Dabora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.